13F-HR filed by Knoll Capital Management, LLC
Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 21 holding rows worth $44,310,096.
- Accession
- 0001104659-23-021561
- Filer
- CIK 1325083
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 21 entries on the cover page, a total value of $44,310,096 stated on the cover page (in dollars after the unit check, H1), rows summing to $44,310,096 with VALUE read as dollars as filed, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,948,090 | $13,558,706 | dollars as filed | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 450,422 | $6,251,857 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 173,864 | $2,860,063 | dollars as filed | |
| VANECK ETF TRUST | 92189F106 | GOLD MINERS ETF | 91,850 | $2,632,421 | dollars as filed | |
| GLOBAL X FDS | 37954Y848 | GLOBAL X SILVER | 89,700 | $2,526,849 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 95,391 | $2,492,567 | dollars as filed | |
| VANECK ETF TRUST | 92189F791 | JUNIOR GOLD MINE | 53,150 | $1,894,797 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 2,450,000 | $1,862,000 | dollars as filed | |
| BOOZ ALLEN HAMILTON HLDG CORP CL A | 099502106 | Stock | 13,000 | $1,358,760 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 14,500 | $1,351,255 | dollars as filed | |
| Orgenesis, Inc. | 68619K105 | COM | 634,738 | $1,237,739 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 2,100 | $1,156,449 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 150,000 | $1,074,000 | dollars as filed | |
| Altria Group Inc | 02209S103 | COM | 22,700 | $1,037,617 | dollars as filed | |
| Visa Inc | 92826C839 | COM | 4,850 | $1,007,636 | dollars as filed | |
| BLACKSTONE GROUP LP | 09253U108 | COM UNIT LTD | 10,000 | $741,900 | dollars as filed | |
| OSISKO GOLD ROYALTIES LTD | 68827L101 | COM | 235,000 | $607,710 | dollars as filed | |
| SEABRIDGE GOLD INC | 811916105 | COM *D* | 41,000 | $515,780 | dollars as filed | |
| Anavex Life Sciences Corp | 003279730 | COM NEW | 10,681 | $98,906 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 50,000 | $40,500 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 2,484,275 | $2,584 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-021561 | this filing | 2023-02-14 | acceptance time not in the bulk data set |